StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
August 31, 2026 9:32 AM
(Updated - August 31, 2026 9:32 AM EDT)
Raymond James analyst Chris Raymond raised the price target on BioMarin ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Hot Comments
Next Articles
Morgan Stanley on BioMarin Pharmaceutical Inc. (BMRN): 'we think the settlement recognizes the value of BioMarin’s pioneering CNP innovation'
August 31, 2026 11:01 AM
Stifel Reiterates Hold Rating on BioMarin Pharmaceutical Inc. (BMRN)
August 31, 2026 9:22 AM